|
[1]
|
Blüher, M. (2014) Adipokines—Removing Road Blocks to Obesity and Diabetes Therapy. Molecular Metabolism, 3, 230-240. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Blüher, M. (2012) Clinical Relevance of Adipokines. Diabetes & Metabolism Journal, 36, 317-327. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Catalan, V., Gomez-Ambrosi, J., Rodriguez, A., Salvador, J. and Fruhbeck, G. (2009) Adipokines in the Treatment of Diabetes Mellitus and Obesity. Expert Opinion on Pharmacotherapy, 10, 239-254. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Coban, M., Tasli, L., Turgut, S., et al. (2016) Association of Adipokines, Insulin Resistance, Hypertension and Dyslipidemia in Patients with Psoriasis Vulgaris. Annals of Dermatology, 28, 74-79. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Ma, J., Niu, D.S., Wan, N.J., et al. (2015) Elevated Chemerin Levels in Synovial Fluid and Synovial Membrane from Patients with Knee Osteoarthritis. International Journal of Clinical and Experimental Pathology, 8, 13393-13398.
|
|
[6]
|
Nagpal, S., Patel, S., Jacobe, H., DiSepio, D., Ghosn, C., Malhotra, M., et al. (1997) Tazarotene-Induced Gene 2 (TIG2), a Novel Retinoid-Responsive Gene in Skin. Journal of Investigative Dermatology, 109, 91-95. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Goralski, K.B., McCarthy, T.C., Hanniman, E.A., Zabel, B.A., Butcher, E.C., Parlee, S.D., et al. (2007) Chemerin, a Novel Adipokine That Regulates Adipogenesis and Adipocyte Metabolism. Journal of Biological Chemistry, 282, 28175-28188. [Google Scholar] [CrossRef]
|
|
[8]
|
Kaur, J., Adya, R., Tan, B.K., et al. (2010) Identification of Chemerin Receptor (ChemR23) in Human Endothelial Cells: Chemerin-Induced Endothelia Angiogenesis. Biochemical and Biophysical Research Communications, 391, 1762-1768. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Zabel, B.A., Allen, S.J., Kulig, P., et al. (2005) Chemerin Activation by Serine Proteases of the Coagulation, Fibrinolytic, and Inflammatory Cascades. Journal of Biological Chemistry, 280, 34661-34666. [Google Scholar] [CrossRef]
|
|
[10]
|
Wittamer, V., Franssen, J.D., Vulcano, M., et al. (2003) Specific Recruitment of Antigen-Presenting Cells by Chemerin, a Novel Processed Ligand from Human Inflammatory Fluids. Journal of Experimental Medicine, 198, 977-985. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Mattern, A., Zellmann, T. and Beck-Sickinger, A.G. (2014) Processing, Signaling, and Physiological Function of Chemerin. IUBMB Life, 66, 19-26. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Fatima, S.S., Rehman, R., Baig, M. and Khan, T.A. (2014) New Roles of the Multidimensional Adipokine: Chemerin. Peptides, 62, 15-20. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Yoshimura, T. and Oppenheim, J.J. (2008) Chemerin Reveals Its Chimeric Nature. Journal of Experimental Medicine, 205, 2187-2190. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Dabke, K., Hendrick, G. and Devkota, S. (2019) The Gut Microbiome and Metabolic Syndrome. Journal of Clinical Investigation, 129, 4050-4057. [Google Scholar] [CrossRef]
|
|
[15]
|
倪青. 代谢综合征病证结合诊疗指南[J/OL]. 世界中医药, 1-16.
http://kns.cnki.net/kcms/detail/11.5529.r.20230208.1603.002.html, 2023-04-11.
|
|
[16]
|
Alberti, K.G., Eckel, R.H., Grundy, S.M., et al (2009) Harmonizing the Metabolic Syndrome: A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation, 120, 1640-1645. [Google Scholar] [CrossRef]
|
|
[17]
|
Bozaoglu, K., Segal, D., Shields, K.A., et al. (2009) Chemerin Is Associated with Metabolic Syndrome Phenotypes in a Mexican-American Population. The Journal of Clinical Endocrinology & Metabolism, 94, 3085-3088. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
NCD Risk Factor Collaboration (NCD-RisC). (2016) Trends in Adult Bodymass Index in 200 Countries from 1975 to 2014: A Pooled Analysis of 1698 Population-Based Measurement Studies with 19∙2 Million Participants. Lancet, 387, 1377-1396.[CrossRef]
|
|
[19]
|
Chu, S.H., Lee, M.K., Ahn, K.Y., et al. (2012) Chemerin and Adiponectin Contribute Reciprocally to Metabolic Syndrome. PLOS ONE, 7, e34710. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Jialal, I., Devaraj, S., Kaur, H., Adams-Huet, B. and Bremer, A.A. (2013) Increased Chemerin and Decreased Omentin-1 in Both Adipose Tissue and Plasma in Nascent Metabolic Syndrome. The Journal of Clinical Endocrinology & Metabolism, 98, E514-517. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Gu, P., Jiang, W., Lu, B. and Shi, Z (2014) Chemerin Is Associated with Inflammatory Markers and Metabolic Syndrome Phenotypes in Hypertension Patients. Clinical and Experimental Hypertension, 36, 326-332. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Kunimoto, H., Kazama, K., Takai, M., Oda, M., Okada, M. and Yamawaki, H. (2015) Chemerin Promotes the Proliferation and Migration of Vascular Smooth Muscle and Increases Mouse Blood Pressure. American Journal of Physiology: Heart and Circulatory Physiology, 309, H1017-H1028. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Roh, S.G., Song, S.H., Choi, K.C., et al. (2007) Chemerin—A New Adipokine That Modulates Adipogenesis via Is Own Receptor. Biochemical and Biophysical Research Communications, 362, 1013-1018. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Jing, L., Zhang, J.Z., Zhao, L., et al. (2007) High Expression of Transforming Growth Factor β and Phosphorylation of Extracellular Signal-Regulated Protein Kinase in Vascular Xmooth Muscle Cells from Aorta and Renal Arterioles of Spontaneous Hypertension Rats. Clinical and Experimental Hypertension, 29, 107-117. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Shamseddeen, H., Getty, J.Z., Hamdallah, I.N. and Ali, M.R. (2011) Epidemiology and Economic Impact of Obesity and Type 2 Diabetes. Surgical Clinics of North America, 91, 1163-1172. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Touys, R.M., He, G., El Mabrouk, M., et al. (2001) P38 Map Kinase Regulates Vascular Smooth Muscle Cell Collagen Synthesis by Angiotensin 11 in SHR but Not in WKY. Hypertension, 37, 574-580. [Google Scholar] [CrossRef]
|
|
[27]
|
Bozaoglu, K., Bolton, K., McMillan, J., Zimmet, P. and Jowett, J. (2007) Chemerin Is a Novel Adipokine Associated with Obesity and Metabolic Syndrome. Endocrinology, 148, 4687-4694. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Gu, P., Jiang, W., Lu, B. and Shi, Z. (2014) Chemerin Is Associated with Inflammatory Markers and Metabolic Syndrome Phenotypes in Hypertension Patients. Clinical and Experimental Hypertension, 36, 326-332. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Castan-Laurell, I., Dray, C., Attane, C., Duparc, T., Knauf, C. and Valet, P. (2011) Apelin, Diabetes, and Obesity. Endocrine, 40, 1-9. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Tunjes, A., Fasshauer, M., Kratzsch, J., et al. (2010) Adipokine Pattern in Subjects with Impaired Fasting Glucose and Impaired Glucose Tolerance in Comparison to Normal Glucose Tolerance and Diabetes. PLOS ONE, 5, e13911. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Bobbert, T., Schwarz, F., Fischer-Rosinsky, A., Maurer, L., Mohlig, M., Pfeiffer, A.F., Mai, K. and Spranger, J. (2015) Chemerin and Prediction of Diabetes Mellitus Type 2. Clinical Endocrinology, 82, 838-843. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Kralisch, S., Weise, S., Sommer, G., et al. (2009) Interleukin-1β Induces the Novel Adipokine Chemerin in Adipocytes in Vitro. Regulatory Peptides, 154, 102-106. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Unamuno, X., Gomez-Ambrosi, J., Rodriguez, A., Becerril, S., Fruhbeck, G. and Catalan, V. (2018) Adipokine Dysregulation and Adipose Tissue Inflammation in Human Obesity. European Journal of Clinical Investigation, 48, e12997. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
路晓荣, 李剑勇. 动物机体胆固醇代谢调控机制研究进展[J]. 动物医学进展, 2019, 40(7): 101-107.
|
|
[35]
|
Maresca, F., Di Palma, V., Bevilacqua, M., et al. (2015) Adipokines, Vascular Wall, Andcardiovascular Disease: A Focused Overview of the Role of Adipokines in the Pathophysiology of Cardiovascular Disease. Angiology, 66, 8-24. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Mancuso, P. (2016) The Role of Adipokines in Chronic Inflammation. ImmunoTargets and Therapy, 5, 47-56. [Google Scholar] [CrossRef]
|
|
[37]
|
Kammerer, A., Staab, H., Herberg, M., et al. (2018) Increased Circulating Chemerininpatients with Advanced Carotid Stenosis. BMC Cardiovascular Disorders, 18, Article No. 65. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Ferland, D.J. and Watts, S.W. (2015) Chemerin: A Comprehensive Review Elucidating the Need for Cardiovascular Research. Pharmacological Research, 99, 351-361. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Kaur, J., Adya, R., Tan, B.K., Chen, J. and Randeva, H.S. (2010) Identification of Chemerin Receptor (ChemR23) in Human Endothelial Cells: Chemerin-Induced Endothelial Angiogenesis. Biochemical and Biophysical Research Communications, 391, 1762-1768. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Hart, R. and Greaves, D.R. (2010) Chemerin Contributes to Inflammation by Promoting Macrophage Adhesion to VCAM-1 and Fibronectin through Clustering of VLA-4 and VLA-5. The Journal of Immunology, 185, 3728-3739. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Zhao, D., Bi, G., Feng, J., Huang, R. and Chen, X. (2015) Association of Serum Chemerin Levels with Acute Ischemic Stroke and Carotid Artery Atherosclerosis in a Chinese Population. Medical Science Monitor, 21, 3121-3128. [Google Scholar] [CrossRef]
|
|
[42]
|
Inci, S., Aksan, G. and Dogan, P. (2016) Chemerin as an Independent Predictor of Cardiovascular Event Risk. Therapeutic Advances in Endocrinology and Metabolism, 7, 57-68. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Leiherer, A., Muendlein, A., Kinz, E., Vonbank, A., Rein, P., Fraunberger, P., et al. (2015) High Plasma Chemerin Is Associated with Renal Dysfunction and Predictive for Cardiovascular Events—Insights from Phenotype and Enotype Characterization. Vascular Pharmacology, 77, 60-68. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Bozaoglu, K., Bolton, K., McMillan, J., Zimmet, P., Jowett, J., Collier, G., Walder, K. and Segal, D. (2007) Chemerin Is a Novel Adipokine Associated with Obesity and Metabolic Syndrome. Endocrinology, 148, 4687-4694. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
De Palma, G., Castellano, G., Del Prete, A., Sozzani, S., Fiore, N., Loverre, A., et al. (2011) The Possible Role of ChemR23/Chemerin Axis in the Recruitment of Dendritic Cells in Lupus Nephritis. Kidney International, 79, 1228-1235. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Bonomini, M. and Pandolfi, A. (2015) Chemerin in Renal Dysfunction and Cardiovascular Disease. Vascular Pharmacology, 77, 28-34. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Hu, W., Yu, Q., Zhang, J. and Liu, D. (2012) Rosiglitazone Ameliorates Diabetic Nephropathy by Reducing the Expression of Chemerin and ChemR23 in the Kidney of Streptozotocin-Induced Diabetic Rats. Inflammation, 35, 1287-1293. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
Jha, V., Garcia-Garcia, G., Iseki, K., Li, Z., Naicker, S., Plattner, B., et al. (2013) Chronic Kidney Disease: Global Dimension and Perspectives. Lancet, 382, 260-272. [Google Scholar] [CrossRef]
|
|
[49]
|
Serhan, C.N. and Savill, J. (2005) Resolution of Inflammation: The Beginning Programs the End. Nature Immunology, 6, 1191-1197. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Bozaoglu, K., Curran, J.E., Stocker, C.J., Zaibi, M.S., Segal, D., Konstantopoulos, N., Morrison, S., Carless, M., Dyer, T.D., Cole, S.A., Goring, H.H., Moses, E.K., Walder, K., Cawthorne, M.A., Blangero, J. and Jowett, J.B. (2010) Chemerin, A Novel Adipokine in the Regulation of Angiogenesis. The Journal of Clinical Endocrinology & Metabolism, 95, 2476-2485. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Skrzeczyn’Ska-Moncznik, J., Stefan’Ska, A., Zabel, B.A., Kapin’Ska-Mrowiecka, M., Butcher, E.C. and Cichy, J. (2009) Chemerin and the Recruitment of NK Cells to Diseased Skin. Acta Biochimica Polonica, 56, 355-360. [Google Scholar] [CrossRef]
|
|
[52]
|
Kumar, J.D., Kandola, S., Tiszlavicz, L., Reisz, Z., Dockray, G.J. and Varro, A. (2016) The Role of Chemerin and ChemR23 in Stimulating the Invasion of Squamous Oesophageal Cancer Cells. British Journal of Cancer, 114, 1152-1159. [Google Scholar] [CrossRef] [PubMed]
|
|
[53]
|
Kaneko, K., Miyabe, Y., Takayasu, A., Fukuda, S., Miyabe, C., Ebisawa, M., Yokoyama, W., Watanabe, K., Imai, T., Muramoto, K., Terashima, Y., Sugihara, T., Matsushima, K., Miyasaka, N. and Nanki, T. (2011) Chemerin Activates Fibroblast-Like Synoviocytes in Patients with Rheumatoid Arthritis. Arthritis Research & Therapy, 13, Article No. R158. [Google Scholar] [CrossRef] [PubMed]
|
|
[54]
|
Weigert, J., Obermeier, F., Neumeier, M., Wanninger, J., Filarsky, M., Bauer, S., Aslanidis, C., Rogler, G., Ott, C., Schaffler, A., Scholmerich, J. and Buechler, C. (2010) Circulating Levels of Chemerin and Adiponectin Are Higher in Ulcerative Colitis and Chemerin Is Elevated in Crohn’s Disease. Inflammatory Bowel Diseases, 16, 630-637. [Google Scholar] [CrossRef] [PubMed]
|
|
[55]
|
Cash, J.L., Hart, R., Russ, A., Dixon, J.P., Colledge, W.H., Doran, J., Hendrick, A.G., Carlton, M.B. and Greaves, D.R. (2008) Synthetic Chemerin-Derived Peptides Suppress Inflammation through ChemR23. Journal of Experimental Medicine, 205, 767-775. [Google Scholar] [CrossRef] [PubMed]
|
|
[56]
|
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D.M., Forman, D. and Bray, F. (2015) Cancer Incidence and Mortality Worldwide: Sources, Methods and Major Patterns in GLOBOCAN 2012. International Journal of Cancer, 136, E359-E386. [Google Scholar] [CrossRef] [PubMed]
|
|
[57]
|
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. [Google Scholar] [CrossRef] [PubMed]
|
|
[58]
|
Dalamaga, M., Diakopoulos, K.N. and Mantzoros, C.S. (2012) The Role of Adiponectin in Cancer: A Review of Current Evidence. Endocrine Reviews, 33, 547-594. [Google Scholar] [CrossRef] [PubMed]
|
|
[59]
|
Choi, J., Cha, Y.J. and Koo, J.S. (2018) Adipocyte Biology in Breast Cancer: From Silent Bystander to Active Facilitator. Progress in Lipid Research, 69, 11-20. [Google Scholar] [CrossRef] [PubMed]
|
|
[60]
|
Sakurai, M., Miki, Y., Takagi, K., Suzuki, T., Ishida, T., Ohuchi, N. and Sasano, H. (2017) Interaction with Adipocyte Stromal Cells Induces Breast Cancer Malignancy via S100A7 Upregulation in Breast Cancer Microenvironment. Breast Cancer Research, 19, Article No. 70. [Google Scholar] [CrossRef] [PubMed]
|
|
[61]
|
Matafome, P., Santos-Silva, D., Sena, C.M. and Seica, R. (2013) Common Mechanisms of Dysfunctional Adipose Tissue and Obesity-Related Cancers. Diabetes/Metabolism Research and Reviews, 29, 285-295. [Google Scholar] [CrossRef] [PubMed]
|
|
[62]
|
Chi, J., Wu, Z., Choi, C.H.J., Nguyen, L., Tegegne, S., Ackerman, S.E., Crane, A., Marchildon, F., Tessier-Lavigne, M. BS Cohen, P. (2018) Three-Dimensional Adipose Tissue Imaging Reveals Regional Variation in Beige Fat Biogenesis and PRDM16-Dependent Sympathetic Neurite Density. Cell Metabolism, 27, 226-236.E3. [Google Scholar] [CrossRef] [PubMed]
|
|
[63]
|
Rourke, J.L., Dranse, H.J. and Sinal, C.J. (2013) Towards an Integrative Approach to Understanding the Role of Chemerin in Human Health and Disease. Obesity Reviews, 14, 245-262. [Google Scholar] [CrossRef] [PubMed]
|
|
[64]
|
Helfer, G. and Wu, Q.F. (2018) Chemerin: A Multifaceted Adipokine Involved in Metabolic Disorders. Journal of Endocrinology, 238, R79-R94. [Google Scholar] [CrossRef]
|
|
[65]
|
Ghallab, N.A. and Shaker, O.G. (2017) Serum and Salivary Levels of Chemerin and MMP-9 in Oral Squamous Cell Carcinoma and Oral Premalignant Lesions. Clinical Oral Investigations, 21, 937-947. [Google Scholar] [CrossRef] [PubMed]
|
|
[66]
|
Parolini, S., Santoro, A., Marcenaro, E., Luini, W., Massardi, L., Facchetti, F., Communi, D., Parmentier, M., Majorana, A., Sironi, M., et al. (2007) the Role of Chemerin in the Colocalization of NK and Dendritic Cell Subsets into Inflamed Tissues. Blood, 109, 3625-3632. [Google Scholar] [CrossRef] [PubMed]
|
|
[67]
|
Pachynski, R.K., Zabel, B.A., Kohrt, H.E., Tejeda, N.M., Monnier, J., Swanson, C.D., Holzer, A.K., Gentles, A.J., Sperinde, G.V., Edalati, A., et al. (2012) the Chemoattractant Chemerin Suppresses Melanoma by Recruiting Natural Killer Cell Antitumor Defenses. Journal of Experimental Medicine, 209, 1427-1435. [Google Scholar] [CrossRef] [PubMed]
|
|
[68]
|
Alkady, M.M., Abdel-Messeih, P.L. and Nosseir, N.M. (2018) Assessment of Serum Levels of the Adipocytokine Chemerin in Colorectal Cancer Patients. Journal of Medical Biochemistry, 37, 313-319. [Google Scholar] [CrossRef] [PubMed]
|
|
[69]
|
Qi, X., Fan, J., Zhu, J., Ling, Y., Mi, S., Chen, H., Fan, C. and Li, Y. (2020) Circulating Chemerin Level and Risk of Cancer: A Systematic Review and Meta-Analysis. Biomarkers in Medicine, 14, 919-928. [Google Scholar] [CrossRef] [PubMed]
|
|
[70]
|
Zhao, L., Zhao, L., Leung, L.L., Leung, L.L. and Morser, J. (2022) Chemerin Forms: Their Generation and Activity. Biomedicines, 10, Article 2018. [Google Scholar] [CrossRef] [PubMed]
|